Category Archives: Medical Devices

Live in the OR Interview Anteris CEO Wayne Paterson

Posted on January 26, 2023 by clinicalaccelerator

Interview with the implanting physicians from the DurAVR First-in-Human Study

Posted in Cardiology, Medical Devices | Leave a comment

Clinical Accelerator announces collaboration with CryoTherapuetics – a medical device company focused on treating coronary artery disease

Posted on January 23, 2023 by clinicalaccelerator

Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a new partnership with CryoTherapeutics – an early-stage European medical device company which has developed a novel cryoenergy therapy for the treatment of inflamed atherosclerotic plaque, … Continue reading →

Posted in Clinical Accelerator, Medical Devices | Leave a comment

Newly Published Chronic Heart Failure Treatment Study Provides Promising Results for EVBA Procedure with Unique MobiusHD Device

Posted on January 18, 2023 by clinicalaccelerator

Below, we are re-publishing with permission the press-release issued by Vascular Dynamics, Inc. on October 18, 2022 Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, … Continue reading →

Posted in Cardiology, Medical Devices | Leave a comment

Miracor Medical Announces FDA IDE Approval For PiCSO® Pivotal Study

Posted on January 10, 2023 by clinicalaccelerator

Below, we are re-publishing with permission the press-release issued by Miracor Medical on August 23, 2022 AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) has announced the approval of an Investigational Device Exemption (IDE) from the FDA, enabling the company to … Continue reading →

Posted in Cardiology, Medical Devices, Uncategorized | Leave a comment

Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON

Posted on November 16, 2022 by clinicalaccelerator

Below, we are re-publishing with permission the press-release issued by Sequana Medical on November 15, 2022 15 November 2022, 07:00 am CET Ghent, Belgium – 15 November 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of … Continue reading →

Posted in Cardiology, Medical Devices | Leave a comment

Maxwell Biomedical Completes First-in-Human Study Enrollment and Testing of Spatial Resynchronization™ Therapy

Posted on October 21, 2022 by clinicalaccelerator

Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on October 20, 2022 Spatial Resynchronization Therapy (SR™T) demonstrates proof-of-concept in repeatedly terminating atrial fibrillation (AFib) and restoring sinus rhythm SAN DIEGO, CALIFORNIA, UNITED STATES, October 20, 2022 … Continue reading →

Posted in Cardiology, Medical Devices | Leave a comment

Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

Posted on October 4, 2022 by clinicalaccelerator

Below, we are re-publishing with permission the press-release issued by Axon Therapies on May 26, 2022 Late-breaking results presented at the European Society of Cardiology’s Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart … Continue reading →

Posted in Cardiology, Medical Devices | Leave a comment

AtriAN Medical Completes Enrollment of Second Study on Cardioneuroablation using PFA

Posted on September 8, 2022 by clinicalaccelerator

Below, we are re-publishing with permission the press-release issued by AtriAN Medical on September 06, 2022 This follow-up trial builds on AtriAN’s initial safety and feasibility study and aims to assess the efficacy of its cardioneuroablation treatment in patients with atrial … Continue reading →

Posted in Cardiology, Medical Devices | Leave a comment

Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device

Posted on July 22, 2022 by clinicalaccelerator

Below, we are re-publishing with permission the press-release issued by Cardiovascular Systems, Inc. on March 16, 2022 ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with … Continue reading →

Posted in Cardiology, Medical Devices | Leave a comment

Maxwell Biomedical Initiates First-in-Human Trial to Assess the Safety and Efficacy of а Novel Pacing Intervention in Patients with Atrial Fibrillation

Posted on July 21, 2022 by clinicalaccelerator

Spatial Resynchronization Therapy™ (SR ™Т) Successfully Terminated Atrial Fibrillation Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on July 14, 2022 SAN DIEGO, Calif., July 14, 2022. Maxwell Biomedical announced today that it has initiated its … Continue reading →

Posted in Cardiology, Medical Devices | Leave a comment